-
平臺(tái)編號(hào)：bio-127789
-
國(guó)際編號(hào)：LMBP 13315
-
拉丁屬名： Escherichia coli
-
規(guī)格：/
-
用途：BCCM原裝進(jìn)口
-
服務(wù)費(fèi)用：
加載中…… - 訂購(gòu) 說(shuō)明書(shū)
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫(kù)為準(zhǔn)）
CmpX131
Species:Escherichia coli
Group:B
Strain designation:CmpX131
Accession number:LMBP 13315
Depositor:Dr T.Mathes1.
1 Experimental Biophysics,Institute of Biology,Humboldt University of Berlin,Berlin,Germany
Containment level:This strain has been assigned the containment level Class 1 following the European Directive 2009/41/EC on the contained use of genetically modified organisms,and its updates(see also the Belgian risk group classification).
Other culture collection numbers:c017
Medium:LB-Lennox+50
Selection marker:/
Temperature:28°C
Genotype:F-ompT gal dcm hsdSB(rB-mB-)(DE3)manX::ribM ribC-
Phenotype:Riboflavin auxotrophy
Properties:The strain is intended for protein production and flavin labelling.As a C41(DE3)derivative,this strain contains DE3,aλprophage carrying the T7 RNA polymerase gene under control of the lacUV5 promoter and lacIq.IPTG is required to induce expression of the T7 RNA polymerase.Protein expression from transforming plasmids containing a T7 promoter-driven expression system is repressed until IPTG induction of T7 RNA polymerase expression occurs.The strain is deficient in the outer membrane protease OmpT which reduces the degradation of heterologous proteins expressed in the strain.
Further information:This strain was created based on E.coli B CmpX13(LMBP 13314)via site specific chromosomal modification.
Original reference:Mathes et al.,J.Mol.Biol.385(2009),1511-1518[PMID:19027027][DOI:10.1016/j.jmb.2008.11.001]
Related reference:Mehlhorn et al.,PLoS One.8(2013),e79006[PMID:24223875][DOI:10.1371/journal.pone.0079006]
Restricted use:-BCCM MTA
Refer in your Materials and Methods:
Escherichia coli B CmpX131(LMBP 13315)is available at BCCM/GeneCorner.It was deposited by Dr T.Mathes and was published in Mathes et al.,2009.
Group:B
Strain designation:CmpX131
Accession number:LMBP 13315
Depositor:Dr T.Mathes1.
1 Experimental Biophysics,Institute of Biology,Humboldt University of Berlin,Berlin,Germany
Containment level:This strain has been assigned the containment level Class 1 following the European Directive 2009/41/EC on the contained use of genetically modified organisms,and its updates(see also the Belgian risk group classification).
Other culture collection numbers:c017
Medium:LB-Lennox+50
Selection marker:/
Temperature:28°C
Genotype:F-ompT gal dcm hsdSB(rB-mB-)(DE3)manX::ribM ribC-
Phenotype:Riboflavin auxotrophy
Properties:The strain is intended for protein production and flavin labelling.As a C41(DE3)derivative,this strain contains DE3,aλprophage carrying the T7 RNA polymerase gene under control of the lacUV5 promoter and lacIq.IPTG is required to induce expression of the T7 RNA polymerase.Protein expression from transforming plasmids containing a T7 promoter-driven expression system is repressed until IPTG induction of T7 RNA polymerase expression occurs.The strain is deficient in the outer membrane protease OmpT which reduces the degradation of heterologous proteins expressed in the strain.
Further information:This strain was created based on E.coli B CmpX13(LMBP 13314)via site specific chromosomal modification.
Original reference:Mathes et al.,J.Mol.Biol.385(2009),1511-1518[PMID:19027027][DOI:10.1016/j.jmb.2008.11.001]
Related reference:Mehlhorn et al.,PLoS One.8(2013),e79006[PMID:24223875][DOI:10.1371/journal.pone.0079006]
Restricted use:-BCCM MTA
Refer in your Materials and Methods:
Escherichia coli B CmpX131(LMBP 13315)is available at BCCM/GeneCorner.It was deposited by Dr T.Mathes and was published in Mathes et al.,2009.
